Navigation Links
Perceptum Group Announces New Situational Leadership V Series
Date:10/2/2009

Company expands its management development service offering with the addition of Situational Leadership V™ series to its portfolio.

San Francisco, Calif. (PRWEB) October 2, 2009 -- Perceptum Group, LLC announced today the introduction of its new Situational Leadership V (SLV) series specifically for biotech and specialty pharma companies. The new series includes Situational Leadership V™, Situational Self Leadership and Advanced Situational Leadership V™.

In Situational Leadership V the Perceptum Group expands upon Hersey and Blanchard's models to now include five developmental levels and leadership styles. Participants are taught to use emotional intelligence concepts, conflict management techniques, and effective communication strategies to facilitate application of situational leadership. Situational Self Leadership teaches life sciences sales representatives, whose time is primarily spent in the field by themselves, on how to acquire the ability to be "self leaders." Advanced Situational Leadership V provides sales managers practical leadership tools they can use to accelerate a sales representative's development from enthusiastic beginner to peak performer.

Perceptum customizes each SLV program to the specific products, market space and sales culture of its biotech and specialty pharma clients. "Delivering programs that are relevant to our life sciences clients by utilizing client-specific, field-based situations greatly enhances the value and effectiveness in achieving desired short and long-term behaviors" said Don Wright, Perceptum's Vice President of Business Development. "The SLV series will provide life sciences companies a common leadership framework throughout their entire organization."

To learn more about Perceptum's Situational Leadership V, go to:

http://www.perceptumgroup.com/specialty-pharmaceutical/situational-leadership-v.php    

or

http://www.perceptumgroup.com/biotechnology/situational-leadership-v.php

About Perceptum Group

The Perceptum Group is the leading training, education and development company for the life sciences industry. Biotechnology, specialty pharmaceutical, and medical device companies seeking to expand and develop their markets rely on the Perceptum Group for sales and physician training as well as development of their sales management professionals. Perceptum catalyzes insights for a company's sales organization, builds their capabilities, mobilizes them to act and helps execute in the field to drive measurable results. The Perceptum Group is a privately held consulting firm headquartered in San Francisco, California providing services in the U.S., EU and Latin America. For more information please visit www.perceptumgroup.com or call 415.495.3331.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb2980874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
Breaking Biology News(10 mins):